Cargando…

Pharmacologic Inhibition of Host Phosphodiesterase-4 Improves Isoniazid-Mediated Clearance of Mycobacterium tuberculosis

The lengthy duration of multidrug therapy needed to cure tuberculosis (TB) poses significant challenges for global control of the disease. Moreover, chronic inflammation associated with TB leads to pulmonary damage that can remain even after successful cure. Thus, there is a great need for the devel...

Descripción completa

Detalles Bibliográficos
Autores principales:	Subbian, Selvakumar, Koo, Mi-Sun, Tsenova, Liana, Khetani, Vikram, Zeldis, Jerome B., Fallows, Dorothy, Kaplan, Gilla
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2016
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4911353/ https://www.ncbi.nlm.nih.gov/pubmed/27379099 http://dx.doi.org/10.3389/fimmu.2016.00238

Ejemplares similares

Phosphodiesterase-4 Inhibition Alters Gene Expression and Improves Isoniazid – Mediated Clearance of Mycobacterium tuberculosis in Rabbit Lungs
por: Subbian, Selvakumar, et al.
Publicado: (2011)

Phosphodiesterase 4 Inhibition Reduces Innate Immunity and Improves Isoniazid Clearance of Mycobacterium tuberculosis in the Lungs of Infected Mice
por: Koo, Mi-Sun, et al.
Publicado: (2011)

Adjunctive Phosphodiesterase-4 Inhibitor Therapy Improves Antibiotic Response to Pulmonary Tuberculosis in a Rabbit Model
por: Subbian, Selvakumar, et al.
Publicado: (2016)

Host Targeted Activity of Pyrazinamide in Mycobacterium tuberculosis Infection
por: Manca, Claudia, et al.
Publicado: (2013)

Early innate immunity determines outcome of Mycobacterium tuberculosis pulmonary infection in rabbits
por: Subbian, Selvakumar, et al.
Publicado: (2013)

Chronic pulmonary cavitary tuberculosis in rabbits: a failed host immune response
por: Subbian, Selvakumar, et al.
Publicado: (2011)

Strain specific transcriptional response in Mycobacterium tuberculosis infected macrophages
por: Koo, Mi-Sun, et al.
Publicado: (2012)

Molecular immunologic correlates of spontaneous latency in a rabbit model of pulmonary tuberculosis
por: Subbian, Selvakumar, et al.
Publicado: (2013)

Thalidomide and Phosphodiesterase 4 Inhibitors as Host Directed Therapeutics for Tuberculous Meningitis: Insights From the Rabbit Model
por: Kumar, Ranjeet, et al.
Publicado: (2020)

Mycobacterium leprae alters classical activation of human monocytes in vitro
por: Fallows, Dorothy, et al.
Publicado: (2016)

A phosphodiesterase-4 inhibitor reduces lung inflammation and fibrosis in a hamster model of SARS-CoV-2 infection
por: Kolloli, Afsal, et al.
Publicado: (2023)

Aggregation state of Mycobacterium tuberculosis impacts host immunity and augments pulmonary disease pathology
por: Kolloli, Afsal, et al.
Publicado: (2021)

Lesion-Specific Immune Response in Granulomas of Patients with Pulmonary Tuberculosis: A Pilot Study
por: Subbian, Selvakumar, et al.
Publicado: (2015)

The resuscitation-promoting factors of Mycobacterium tuberculosis are required for virulence and resuscitation from dormancy but are collectively dispensable for growth in vitro
por: Kana, Bavesh D, et al.
Publicado: (2008)

Binding of activated isoniazid with acetyl-CoA carboxylase from Mycobacterium tuberculosis
por: Unissa, Ameeruddin Nusrath, et al.
Publicado: (2011)

Correlation of rpoB Mutations with Minimal Inhibitory Concentration of Rifampin and Rifabutin in Mycobacterium tuberculosis in an HIV/AIDS Endemic Setting, South Africa
por: Rukasha, Ivy, et al.
Publicado: (2016)

A combination of baseline plasma immune markers can predict therapeutic response in multidrug resistant tuberculosis
por: Ferrian, Selena, et al.
Publicado: (2017)

Caseation of human tuberculosis granulomas correlates with elevated host lipid metabolism
por: Kim, Mi-Jeong, et al.
Publicado: (2010)

A Subset of Circulating Blood Mycobacteria-Specific CD4 T Cells Can Predict the Time to Mycobacterium tuberculosis Sputum Culture Conversion
por: Riou, Catherine, et al.
Publicado: (2014)

Minimum inhibitory concentrations of rifampin and isoniazid among multidrug and isoniazid resistant Mycobacterium tuberculosis in Ethiopia
por: Getahun, Muluwork, et al.
Publicado: (2022)

Biphasic Dynamics of Macrophage Immunometabolism during Mycobacterium tuberculosis Infection
por: Shi, Lanbo, et al.
Publicado: (2019)

Frequency of Circulating CD4(+)Ki67(+)HLA-DR(−) T Regulatory Cells Prior to Treatment for Multidrug Resistant Tuberculosis Can Differentiate the Severity of Disease and Predict Time to Culture Conversion
por: Ferrian, Selena, et al.
Publicado: (2018)

Vaccination with an Attenuated Ferritin Mutant Protects Mice against Virulent Mycobacterium tuberculosis
por: Subbian, Selvakumar, et al.
Publicado: (2015)

Effect of Iron Supplementation on the Outcome of Non-Progressive Pulmonary Mycobacterium tuberculosis Infection
por: Kolloli, Afsal, et al.
Publicado: (2019)

Host-Directed Therapeutic Strategies for Tuberculosis
por: Kolloli, Afsal, et al.
Publicado: (2017)

Effects of Everolimus in Modulating the Host Immune Responses against Mycobacterium tuberculosis Infection
por: Raien, Anmol, et al.
Publicado: (2023)

Discovery of Novel Enhancers of Isoniazid Toxicity in Mycobacterium tuberculosis
por: Lentz, Fabian, et al.
Publicado: (2018)

Redox Imbalance and Oxidative DNA Damage During Isoniazid Treatment of HIV-Associated Tuberculosis: A Clinical and Translational Pharmacokinetic Study
por: Zentner, Isaac, et al.
Publicado: (2020)

Investigation of Ser315 Substitutions within katG Gene in Isoniazid-Resistant Clinical Isolates of Mycobacterium tuberculosis from South India
por: Unissa, A. Nusrath, et al.
Publicado: (2015)

Immunometabolism of Phagocytes During Mycobacterium tuberculosis Infection
por: Kumar, Ranjeet, et al.
Publicado: (2019)

‘Z(S)-MDR-TB' versus ‘Z(R)-MDR-TB': improving treatment of MDR-TB by identifying pyrazinamide susceptibility
por: Zhang, Ying, et al.
Publicado: (2012)

Imaging Architecture of Granulomas Induced by Mycobacterium tuberculosis Infections with Single-Molecule FISH
por: Kumar, Ranjeet, et al.
Publicado: (2023)

The molecular basis of resistance to isoniazid, rifampin, and pyrazinamide in Mycobacterium tuberculosis
por: Somoskovi, Akos, et al.
Publicado: (2001)

Impact of Bacterial Genetics on the Transmission of Isoniazid-Resistant Mycobacterium tuberculosis
por: Gagneux, Sebastien, et al.
Publicado: (2006)

Contribution of Efflux to the Emergence of Isoniazid and Multidrug Resistance in Mycobacterium tuberculosis
por: Machado, Diana, et al.
Publicado: (2012)

Isoniazid resistance without a loss of fitness in Mycobacterium tuberculosis
por: Lee, Jong-Hee, et al.
Publicado: (2012)

Effect of efflux pump inhibitors on the susceptibility of Mycobacterium tuberculosis to isoniazid
por: Jaiswal, Indu, et al.
Publicado: (2017)

Effect of Standard Tuberculosis Treatment on Plasma Cytokine Levels in Patients with Active Pulmonary Tuberculosis
por: Riou, Catherine, et al.
Publicado: (2012)

Editorial: Host-Directed Therapies for Tuberculosis
por: Costa, Diego L., et al.
Publicado: (2021)

Detecting Novel Genetic Variants Associated with Isoniazid-Resistant Mycobacterium tuberculosis
por: Shekar, Sandhya, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_tmll2ui9d99anl6dgs6t8thlb5